Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
5.51
+0.06 (1.10%)
Aug 8, 2025, 4:00 PM - Market closed
Serina Therapeutics Market Cap
Serina Therapeutics has a market cap or net worth of $54.92 million as of August 8, 2025. Its market cap has decreased by -35.67% in one year.
Market Cap
54.92M
Enterprise Value
51.07M
1-Year Change
-35.67%
Ranking
Category
Stock Price
5.51
Market Cap Chart
Since March 27, 2024, Serina Therapeutics's market cap has decreased from $125.13M to $54.92M, a decrease of -56.11%. That is a compound annual growth rate of -45.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 54.92M | 16.72% |
| Dec 31, 2024 | 47.05M | -62.40% |
| Mar 27, 2024 | 125.13M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 670.04B |
| Johnson & Johnson | 410.84B |
| AbbVie | 346.78B |
| AstraZeneca | 228.71B |
| Abbott Laboratories | 227.88B |
| UnitedHealth Group | 222.96B |
| Novartis AG | 221.76B |
| Novo Nordisk | 200.63B |